抗艾药品绥美凯怎么样

(Domitabalamid Tablets, Inbec) is a new drug used to treat AIDS, bringing new hope to AIDS patients. AIDS is an infectious disease that can be transmitted through sexual contact, blood, and mother-to-child transmission. Currently, there is still a lack of effective drugs to cure HIV infection worldwide. It can only reduce the viral load to the maximum and lasting extent and improve the patient's quality of life.

  How about the anti-AIDS drug Suimeikan?

Judging from a large number of clinical trial data, DTG has a low discontinuation rate due to adverse drug reactions (ADR) or virological failure, which are 5.8% and 0.5% respectively. The ADR drops significantly after one year of taking the drug. The most common adverse reactions are gastrointestinal dysfunction, mental disorders and neurological disorders, but the adverse reaction rates are less than 1.5%. Comparing it with the other two integrase inhibitors RAL (Ascent) and EVG (elvitegravir) in patients who failed the first-line treatment, Suimeike (Dolutea Balamib Tablets, Inbec) has significantly fewer drug-resistant mutation sites than the other two drugs, making it less likely to develop drug resistance.

Suimeikai (Domitabalamid Tablets, Inbec) has the characteristics of good efficacy and few side effects in treating HIV. Its common side effects include: nausea/insomnia/dizziness/headache, etc. Patients with abacavir hypersensitivity often experience nausea/vomiting/diarrhea/fever/drowsiness/rash and other symptoms when using Suimeike (dolute abalamide tablets, Inbec). Patients who are allergic to any of the ingredients in Suimeike (Dotiabalamid Tablets, Inbec) should not use this drug for treatment. Before receiving treatment with this drug, patients should go to the hospital for a detailed examination and take the drug according to the doctor's diagnosis and treatment recommendations.

The above is the introduction about (Abalami Tablets, Inbec), I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service. 

Recommended related hot articles: /newsDetail/80730.html